Prostate Specific Antigen for Assessing Response to Ketoconazole and Prednisone in Patients with Hormone Refractory Metastatic Prostate Cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
1987 • 2,447 citations
Clinical use of Prostate Specific Antigen in Patients with Prostate Cancer
1989 • 511 citations
Ketoconazole Blocks Adrenal Steroid Synthesis
1982 • 425 citations
The Use of Ketoconazole as an Inhibitor of Steroid Production
1987 • 391 citations
High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects.
1989 • 83 citations
Objective Responses to Ketoconazole Therapy in Patients with Relapsed Progressive Prostatic Cancer
1986 • 72 citations
Ketoconazole: A Possible Direct Cytotoxic Effect on Prostate Carcinoma Cells
1989 • 61 citations
Long-Term Experience with High Dose Ketoconazole Therapy in Patients with Stage D2 Prostatic Carcinoma
1987 • 53 citations
The Role of Prostate Specific Antigen as a Tumor Marker in Men with Advanced Adenocarcinoma of the Prostate
1989 • 31 citations
High Dose Ketoconazole for the Treatment of Hormone Refractory Metastatic Prostate Carcinoma: 16 Cases and Review of the Literature
1989 • 30 citations
Ketoconazole Therapy for Advanced Prostatic Cancer: Feasibility and Treatment Results
1987 • 27 citations
Introduction
1980 • 14 citations
Deleted Work
1955 • 0 citations